文献速递甲状腺核医学核素与放射性配体治疗

儿童分化型甲状腺癌的放射性碘治疗:剂量测定、临床照护与未来挑战

Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer: Dosimetry, Clinical Care, and Future Challenges.
PubMed 文献 · Clin Nucl Med · 2022-10-14

本文综述儿童及年轻成人分化型甲状腺癌(DTC)术后131I治疗的现有方法及多项研究获得的剂量学数据。儿童DTC指南推荐患者特异性剂量测定,但因发病率低和操作困难尚未常规采用;作者倾向三维剂量测定而非平面剂量测定,并认为124I PET/CT剂量测定有望给出准确结果。目前缺乏比较经验性131I治疗与剂量测定指导治疗结局的随机对照试验。

要点

  • 儿童DTC术后131I治疗已确立,但指南未明确可安全有效给予的131I最佳剂量。
  • 儿童DTC指南推荐患者特异性剂量测定,但因发病率低和操作困难尚未建立或常规采用。
  • 作者倾向三维剂量测定而非平面剂量测定,并认为124I PET/CT剂量测定有望给出准确结果。

核心结论

  • 目前尚无令人信服的研究比较经验性131I治疗与剂量测定指导治疗在儿童及年轻成人中的结局,需要随机对照试验来解决这一问题。

研究设计与样本

  • 本文为综述,讨论儿童及年轻成人DTC患者131I治疗的当前方法及多项研究者获得的剂量学数据。

主要发现

  • 儿童DTC术后131I治疗已确立,但指南未明确可安全有效给予的131I最佳剂量。
  • 儿童与成人DTC一样,经验性131I治疗基于年龄或体重给予。
  • 儿童DTC指南推荐患者特异性剂量测定重要,但因发病率低和剂量测定实际操作困难,尚未建立或常规采用。
  • 作者倾向三维剂量测定而非平面剂量测定,因三维剂量测定可准确测量病灶大小。
  • 作者认为124I PET/CT剂量测定有望给出准确的剂量学结果。

关键数值与推荐

  • 儿童DTC指南推荐患者特异性剂量测定在儿童中重要。
  • 儿童DTC指南未明确可安全有效给予的131I最佳剂量。
  • 儿童与成人DTC一样,经验性131I治疗基于年龄或体重给予。
  • 作者倾向三维剂量测定而非平面剂量测定。
  • 作者认为124I PET/CT剂量测定有望给出准确的剂量学结果。

临床怎么用

  • 儿童DTC术后131I治疗已确立;儿童与成人DTC一样,经验性131I治疗基于年龄或体重给予。
  • 儿童DTC指南推荐患者特异性剂量测定重要,但因发病率低和剂量测定实际操作困难,尚未建立或常规采用。
  • 作者倾向三维剂量测定而非平面剂量测定,并认为124I PET/CT剂量测定有望给出准确结果。

局限性

  • 儿童DTC指南未明确可安全有效给予的131I最佳剂量。
  • 由于发病率低和剂量测定实际操作困难,患者特异性剂量测定尚未建立或常规采用。
  • 目前没有随机对照试验比较经验性131I治疗与剂量测定指导治疗在儿童及年轻成人中的结局。
  • 目前没有令人信服的研究比较经验性131I治疗与剂量测定指导治疗的结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thyroid cancer is very rare in children. 131 I therapy after thyroidectomy is established in pediatric differentiated thyroid cancer (DTC). Pediatric DTC guideline is silent on the optimum amount of 131 I that could be safely and effectively administered to children who are more radiosensitive. Like adult DTC, children are also given 131 I therapy empirically based either on age or body weight. Pediatric DTC guideline recommends that patient-specific dosimetry is important in children. Still, due to the low incidence rate and the practical difficulties of dosimetry, it has neither been established nor adopted in routine practice. This review article aims to discuss current approaches of 131 I therapy in children and young adult patients with DTC and dosimetric data obtained by several investigators. Efforts are required to simplify dosimetric procedures and precise results, especially in determining lesion size. We prefer 3-dimensional dosimetry over planar dosimetry, where lesion size could be measured accurately. 124 I PET/CT-based dosimetry is expected to give accurate dosimetric results. The most challenging aspect is that no randomized controlled trials are available to compare the empiric 131 I therapy results versus dosimetry-based treatment outcomes in children and young adults. Suppose dosimetry-based 131 I therapy could be shown to have better outcomes, namely, successful ablation rate, better disease-free survival, and lesser treatment-emergent adverse events than empirical 131 I treatment. In that case, one can argue in favor of the former. Unfortunately, no convincing study is currently available. Thus, there is a need for a randomized control trial to settle this issue.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kumar P, Damle NA, Bal C, et al. Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer: Dosimetry, Clinical Care, and Future Challenges. Clin Nucl Med. 2022. PMID: 36240802. doi:10.1097/RLU.0000000000004431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。